From: Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
N (%)
Satisfaction-intent to continuation
Yes
23 (65,7%)
No
12 (34,3%)
Completed 3 months trial
27 (81,8%)
6 (18,2%)